Outlook Therapeutics (OTLK) Invested Capital (2015 - 2026)
Outlook Therapeutics' Invested Capital was -$8.03 million in fiscal Q2 2026 (quarter ended Mar 31, 2026), compared with $582,395 a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) Invested Capital (2015 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Invested Capital at Outlook Therapeutics came in at $27.71 million.
- Invested Capital shows a five-year compound annual growth rate of 30.2% (FY2020 to FY2025).
- In earlier fiscal years, Invested Capital was -$43.64 million in FY2024, $21.11 million in FY2023 (+7.4%), $19.65 million in FY2022 (+19.8%) and $16.4 million in FY2021 (+121.8%).
- The fiscal Q2 2026 figure marks the lowest quarterly Invested Capital since fiscal Q1 2025.
- The best year-over-year quarter for Invested Capital over five years was fiscal Q4 2021 (growth of 121.8%); the worst was fiscal Q1 2024 (a decline of 74.4%).
- Per Business Quant data, OTLK's Invested Capital in the three fiscal quarters before Q2 2026 was -$1.89 million (Q1 2026), $27.71 million (Q4 2025) and -$2.75 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Outlook Therapeutics | 77.94 Mn | 42.19 Mn | -8,265.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -8.03 Mn |
| Dec 31, 2025 | -1.89 Mn |
| Sep 30, 2025 | 27.71 Mn |
| Jun 30, 2025 | -2.75 Mn |
| Mar 31, 2025 | 582,395.00 |
| Dec 31, 2024 | -19.55 Mn |
| Sep 30, 2024 | -43.64 Mn |
| Jun 30, 2024 | -51.24 Mn |
| Mar 31, 2024 | -89.49 Mn |
| Dec 31, 2023 | 12.20 Mn |
| Sep 30, 2023 | 21.11 Mn |
| Jun 30, 2023 | 29.23 Mn |
| Mar 31, 2023 | 42.31 Mn |
| Dec 31, 2022 | 47.58 Mn |
| Sep 30, 2022 | 19.65 Mn |
| Jun 30, 2022 | 30.54 Mn |
| Mar 31, 2022 | 58.74 Mn |
| Dec 31, 2021 | 71.14 Mn |
| Sep 30, 2021 | 16.40 Mn |
| Jun 30, 2021 | 24.30 Mn |
API Access
Outlook Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();